Delta Asia International Corporation (TPEX:6762)
Taiwan · Delayed Price · Currency is TWD 185.00
-0.50 (-0.27%)
At close: Dec 31, 2025
Delta Asia International Market Cap
Delta Asia International has a market cap or net worth of 6.51 billion as of December 31, 2025. Its market cap has decreased by -25.27% in one year.
Market Cap
6.51B
Enterprise Value
7.74B
Revenue
711.19M
Ranking
n/a
PE Ratio
109.73
Stock Price
185.00
Market Cap Chart
Since December 18, 2019, Delta Asia International's market cap has increased from 2.96B to 6.51B, an increase of 119.83%. That is a compound annual growth rate of 13.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 6.51B | -21.84% |
| Dec 27, 2024 | 8.32B | 19.54% |
| Dec 29, 2023 | 6.96B | 16.96% |
| Dec 30, 2022 | 5.95B | 4.15% |
| Dec 30, 2021 | 5.72B | 14.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.42B |
| Bora Pharmaceuticals Co., LTD. | 60.90B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 31.06B |